Related Experiment Videos
[Barrett esophagus and Barrett carcinoma]
P H Kruyt1, J W van Sandick, J J van Lanschot
1Afd. Chirurgie, Universiteit van Amsterdam/Academisch Medisch Centrum.
Nederlands Tijdschrift Voor Geneeskunde
|May 3, 1997
Summary
Barrett carcinoma incidence has risen significantly. Regular endoscopic screening and biopsies are crucial for early detection and management of Barrett esophagus, especially with high-grade dysplasia, to prevent malignant transformation.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Context:
- Barrett esophagus is a metaplastic change in the esophageal lining, often caused by chronic gastroesophageal reflux.
- This condition significantly increases the risk of developing esophageal adenocarcinoma.
- The incidence of Barrett carcinoma has seen a near six-fold increase over the past two decades.
Purpose:
- To define Barrett esophagus and its association with gastroesophageal reflux.
- To highlight the increased risk of malignant transformation in intestinal metaplasia within the esophagus.
- To outline current recommendations for patient surveillance and treatment strategies.
Summary:
- Barrett esophagus involves metaplastic columnar epithelium in the esophagus, linked to chronic reflux.
- Intestinal metaplasia presents a heightened risk for malignant degeneration.
- Regular endoscopic surveillance with biopsies is advised for patients with Barrett esophagus.
- While low-grade dysplasia doesn't mandate immediate treatment, high-grade dysplasia indicates prophylactic resection.
- Surgery remains the primary treatment for curative intent in Barrett carcinoma.
Impact:
- Emphasizes the need for vigilant monitoring of patients with Barrett esophagus.
- Informs clinical decision-making regarding surveillance frequency and intervention thresholds.
- Underscores the importance of early detection and surgical intervention for Barrett carcinoma.
- Contributes to understanding the progression from metaplasia to malignancy in the esophagus.